Clinical Study

Twice-Daily versus Once-Daily Pramipexole Extended Release Dosage Regimens in Parkinson’s Disease

Table 2

Dose switches from conventional dopaminergic agonist to pramipexole ER.

Pramipexole IR pramipexole ERRopinirole pramipexole ER
Pramipexole IR daily dose, mgPramipexole ER, mgRopinirole daily dose, mgPramipexole ER, mg
Once-dailyTwice-dailyOnce-dailyTwice-daily

0.7 ≤ pramipexole < 0.80.750.375-0.3753.0 ≤ ropinirole < 4.00.750.375-0.375
0.8 ≤ pramipexole < 1.11.1250.75-0.3754.0 ≤ ropinirole < 7.01.1250.75-0.375
1.1 ≤ pramipexole < 1.61.50.75-0.757.0 ≤ ropinirole < 8.01.50.75-0.75
1.6 ≤ pramipexole < 1.91.8751.125-0.758.0 ≤ ropinirole < 10.01.8751.125-0.75
1.9 ≤ pramipexole < 2.32.251.125-1.12510.0 ≤ ropinirole < 12.02.251.125-1.125
2.3 ≤ pramipexole < 2.72.6251.5-1.12512.0 ≤ ropinirole < 14.02.6251.5-1.125
2.7 ≤ pramipexole < 3.13.01.5-1.514.0 ≤ ropinirole < 16.03.01.5-1.5
3.1 ≤ pramipexole < 3.43.3751.875-1.516.0 ≤ ropinirole < 17.03.3751.875-1.5
3.4 ≤ pramipexole < 3.83.751.875-1.87517.0 ≤ ropinirole < 19.03.751.875-1.875
3.8 ≤ pramipexole < 4.24.1252.25-1.87519.0 ≤ ropinirole < 21.04.1252.25-1.875
4.2 ≤ pramipexole < 4.64.52.25-2.2521.0 ≤ ropinirole < 23.04.52.25-2.25
4.6 ≤ pramipexole < 4.94.8752.625-2.2523.0 ≤ ropinirole < 25.04.8752.625-2.25

IR, immediate-release; ER, extended-release.